bay1128688
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2015 (NCT02434640)
Timeline
Indications
Studied for
Mechanism of action
AKR1C3 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bay1128688
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03373422 | Phase 2 | Nov 30, 2017 | Bayer |
| NCT02434640 | Phase 1 | Apr 1, 2015 | Bayer |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bayer | For profit | 2 | 2 | 2 | 2015 |
1 organizations
Page 1 / 1